Kathryn Ottolino-Perry

Intelligent Design: Combination Therapy With Oncolytic Viruses.

J. Diallo, J. Bell, B. Lichty, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Intelligent design: combination therapy with oncolytic viruses.

J. Diallo, J. Bell, B. Lichty, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Oncolytic vaccinia virus synergizes with irinotecan in colorectal cancer

J. A. McCart, Kathryn Ottolino-Perry, S. Acuna, 2015, Molecular oncology.

Oncolytic Vaccinia Virus as an Adjuvant Treatment to Cytoreductive Surgery for Malignant Peritoneal Mesothelioma

J. A. McCart, Kathryn Ottolino-Perry, S. Acuna, 2014, Annals of Surgical Oncology.

Improved detection of clinically relevant wound bacteria using autofluorescence image‐guided sampling in diabetic foot ulcers

R. Dacosta, T. Panzarella, C. Rosen, 2017, International wound journal.

Antiproliferative effects of 111In- or 177Lu-DOTATOC on cells exposed to low multiplicity-of-infection double-deleted vaccinia virus encoding somatostatin subtype-2 receptor.

R. Reilly, J. A. McCart, Kathryn Ottolino-Perry, 2010, Cancer biotherapy & radiopharmaceuticals.

Oncolytic Vaccinia Virus for the Treatment of Peritoneal Carcinomatosis: Combination with Chemotherapy or Targeted Radiotherapy

Kathryn Ottolino-Perry, K. Ottolino‐Perry, 2015 .

Antiangiogenic Arming of an Oncolytic Vaccinia Virus Enhances Antitumor Efficacy in Renal Cell Cancer Models

A. Ristimäki, A. Hemminki, K. Guse, 2009, Journal of Virology.

VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection.

H. Atkins, J. Diallo, D. Kirn, 2015, Cancer cell.